• Profile

Prognostic value of baseline inflammation in diabetic and nondiabetic patients undergoing PCI

Canadian Journal of Cardiology Feb 15, 2022

Regardless of diabetic status, worse ischemic outcomes were observed in patients undergoing percutaneous coronary intervention (PCI) with high levels of high sensitivity C-reactive protein (hsCRP) (defined as >3 mg/L).

  • In this study of 11,979 participants, the prognostic value of hsCRP levels was assessed in diabetic and nondiabetic patients undergoing PCI.

  • Among nondiabetics and diabetics, 24.7% and 29.8% of patients, respectively, had high hsCRP levels.

  • Elevated rates of major adverse cardiovascular events were found in both diabetics and nondiabetics with high hsCRP levels, vs their counterparts with low hsCRP, primarily driven by elevated rates all cause deaths.

  • Only in diabetics, increased rates of target vessel revascularization and myocardial infarction were observed in relation to high hsCRP levels, but there was no significant interaction between inflammation and diabetes.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
M3 app logo
Choose easy access to M3 India from your mobile!

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen